Rebecca Byam

Executive Officer at HCW Biologics.

Miramar, FL
HCW Biologics

Raised on HCW Biologics filings

$4M

of $4M offered across 1 Form D filing

Form D filings: 1
Teammates: 6
Last filing: Jun 8, 2026

Company

Biotech · Miramar, FL

Fusion protein drugs for inflammation-driven disease

Fusion protein drugs for inflammation-driven disease

Investors: 7

Investors: 7
Sector: Biotech
HQ: Miramar, FL

HCW Biologics filings

HCW Biologics Form D filings
Filed	Security	Sold of offered	Filing
Jun 8, 2026	Equity	$4M/ $4M	Form D

EquityFiled Jun 8, 2026Form D
$4M/ $4M

Works with

Also named on HCW Biologics filings

Hing C. WongChief Executive Officer, Form D signerForm D signer Peter RhodeExecutive Officer Lisa M. GilesDirector Rick S. GreeneDirector Scott T. GarrettDirector Lee FlowerExecutive Officer